Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Down 1.8%

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) traded down 1.8% during mid-day trading on Tuesday . The stock traded as low as $3.80 and last traded at $3.85. 6,175 shares were traded during trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $3.92.

About Ampliphi Biosciences (NYSEAMERICAN:APHB)

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.

Featured Story: Why is the ex-dividend date different from the record date?

Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.